Vident Investment Advisory Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novanta
NOVT
|
+$18.9M |
| 2 |
IRBT
iRobot
IRBT
|
+$18.1M |
| 3 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$18M |
| 4 |
Oceaneering
OII
|
+$17M |
| 5 |
3D Systems Corp
DDD
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$14.9M |
| 2 |
TechnipFMC
FTI
|
+$13.5M |
| 3 |
Accuray
ARAY
|
+$10.8M |
| 4 |
Immersion
IMMR
|
+$8.19M |
| 5 |
XONE
The ExOne Company
XONE
|
+$4.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.66% |
| 2 | Industrials | 13.74% |
| 3 | Healthcare | 10.47% |
| 4 | Consumer Discretionary | 8.12% |
| 5 | Financials | 7.3% |
Similar funds
Vident Investment Advisory's Q4 2017 Portfolio in Review
As of Q4 2017, Vident Investment Advisory held 845 positions worth $2.22B, up 20% from $1.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Vident Investment Advisory deployed $293M of net new capital in Q4 2017, opening 119 new positions and adding to 485 existing holdings. Its largest new stake was Novanta: 388,786 shares worth $19.4M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Northrop Grumman, an estimated $14.9M trimmed.
- Vident Investment Advisory's largest Q4 2017 buy was Novanta: 388,786 shares worth $19.4M.
- Vident Investment Advisory added most to iRobot in Q4 2017, an estimated $18.1M increase.
- Vident Investment Advisory's biggest Q4 2017 reduction was Northrop Grumman, cutting an estimated $14.9M.
- Vident Investment Advisory fully exited TechnipFMC in Q4 2017, selling an estimated $13.5M.
- Vident Investment Advisory's ten largest holdings make up 18% of its $2.22B portfolio in Q4 2017.
- Vident Investment Advisory opened 119 new positions and closed 64 in Q4 2017.
- Vident Investment Advisory's portfolio value rose 20% quarter-over-quarter to $2.22B.
Based on Vident Investment Advisory's 13F filing for Q4 2017, filed 15 Feb 2018.